Novo Nordisk A/S (CPH:NOVO.B)
295.50
+0.25 (0.08%)
Aug 28, 2026, 4:59 PM CET
Novo Nordisk Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Hold" and an average price target of kr 310.82. The average 1-year stock price forecast is 5.18% higher than the current stock price, while the lowest is kr 203.00 (-31.30%) and the highest is kr 457.00 (+54.65%).
Price Target: kr 310.82 (+5.18%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Novo Nordisk stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 5 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 18 | 18 | 18 | 17 | 18 | 17 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 2 |
| Total | 25 | 25 | 26 | 26 | 26 | 25 |
Financial Forecast
Revenue This Year
299.47B
from 309.06B
Decreased by -3.10%
Revenue Next Year
304.06B
from 299.47B
Increased by 1.53%
EPS This Year
21.42
from 23.03
Decreased by -6.99%
EPS Next Year
21.86
from 21.42
Increased by 2.04%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.